Suchergebnisse - "Yin, Guosheng"

PubPharm (86)

1

Biostatistics pitfalls : Lessons learned from analysis of medical data

enthalten in: Contemporary clinical trials | 2019

von Yin, G. | Zhang, C. | Yang, Z.

CommentIn: Contemp Clin Trials. 2020 Feb;89:105916. - PMID 31899370

2

Reanalysis of Data Comparing Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer

enthalten in: JAMA oncology | 2019

von Yin, G. | Zhang, C.

3

Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies

enthalten in: Circulation | 2019

von McCaw, Z. | Yin, G. | Wei, L.

4

Design of Noninferiority Trials for Hypofractionated vs Conventional Radiotherapy Among Patients With Cancer

enthalten in: JAMA oncology | 2019

von Yin, G. | McCaw, Z.

5

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

enthalten in: The New England journal of medicine | 2019

von Yang, Z. | McCaw, Z. | Yin, G.

CommentOn: N Engl J Med. 2019 Jan 24;380(4):335-346. - PMID 30625070

6

Radical Surgery or Watchful Waiting in Prostate Cancer

enthalten in: The New England journal of medicine | 2019

von Yang, Z. | McCaw, Z. | Yin, G.

CommentOn: N Engl J Med. 2018 Dec 13;379(24):2319-2329. - PMID 30575473

7

Non-parametric overdose control for dose finding in drug combination trials

Erschienen: 2019

von Lam, C. | Lin, R. | Yin, G.

8

Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015

enthalten in: Frontiers in oncology | 2019

von Zhong, Y. | Wen, Y. | Wong, H. | +3

9

An alternative approach for estimating the number needed to treat for survival endpoints

enthalten in: PloS one | 2019

von Yang, Z. | Yin, G.

10

Non‐parametric overdose control for dose finding in drug combination trials

enthalten in: Journal of the Royal Statistical Society | 2019

von Lam, C. | Lin, R. | Yin, G.

1
2
3
4
5
6
7
8
9
Nächster »
[9]